Carson Wealth (CWM LLC)
VNDA icon

Carson Wealth (CWM LLC)’s Vanda Pharmaceuticals VNDA Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$535K Buy
77,366
+50,387
+187% +$389K ﹤0.01% 1966
2025
Q4 		$238K Sell
26,979
-6,167
-19% -$33.9K ﹤0.01% 2427
2025
Q3 		$165K Buy
33,146
+23,787
+254% +$110K ﹤0.01% 2593
2025
Q2 		$44K Buy
9,359
+7,575
+425% +$33.1K ﹤0.01% 3384
2025
Q1 		$8K Buy
1,784
+726
+69% +$3.38K ﹤0.01% 4243
2024
Q4 		$5K Sell
1,058
-639
-38% -$3.07K ﹤0.01% 4248
2024
Q3 		$8K Sell
1,697
-253
-13% -$1.36K ﹤0.01% 3911
2024
Q2 		$11K Buy
1,950
+1,014
+108% +$5.24K ﹤0.01% 3506
2024
Q1 		$4K Sell
936
-6,657
-88% -$26.6K ﹤0.01% 3795
2023
Q4 		$32K Buy
7,593
+388
+5% +$1.57K ﹤0.01% 2480
2023
Q3 		$31K Buy
7,205
+2,732
+61% +$15.2K ﹤0.01% 2398
2023
Q2 		$29K Buy
4,473
+1,823
+69% +$11.7K ﹤0.01% 2401
2023
Q1 		$18K Buy
2,650
+893
+51% +$6.28K ﹤0.01% 2593
2022
Q4 		$13K Buy
1,757
+1,639
+1,389% +$16K ﹤0.01% 2671
2022
Q3 		$1K Buy
118
+77
+188% +$813 ﹤0.01% 3790
2022
Q2 		$0 Sell
41
-41
-50% -$425 ﹤0.01% 4115
2022
Q1 		$1K Sell
82
-189
-70% -$2.48K ﹤0.01% 3431
2021
Q4 		$4K Buy
+271
New +$4.72K ﹤0.01% 2897
2021
Q2 		$1K Hold
41
– – ﹤0.01% 2861
2021
Q1 		$1K Hold
41
– – ﹤0.01% 2860
2020
Q4 		$1K Hold
41
– – ﹤0.01% 2860
2020
Q3 		$1K Hold
41
– – ﹤0.01% 2857
2020
Q2 		$1K Hold
41
– – ﹤0.01% 2857
2020
Q1 		$1K Hold
41
– – ﹤0.01% 2855
2019
Q4 		$1K Hold
41
– – ﹤0.01% 2855
2019
Q3 		$1K Hold
41
– – ﹤0.01% 2855
2019
Q2 		$1K Hold
41
– – ﹤0.01% 2855
2019
Q1 		$1K Buy
+41
New +$934 ﹤0.01% 2853

Other funds holding VNDA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Carson Wealth (CWM LLC)'s VNDA Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Vanda Pharmaceuticals (VNDA) stake by 187% in Q1 2026, buying an estimated $389K and bringing the position to 77,366 shares worth $535K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

Carson Wealth (CWM LLC) first reported a position in VNDA in Q1 2019 and has held it in 28 quarters since. 171 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Carson Wealth (CWM LLC) held 77,366 shares of Vanda Pharmaceuticals worth $535K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 50,387 Vanda Pharmaceuticals shares in Q1 2026, an estimated $389K.
  • Vanda Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #1966 holding.
  • Carson Wealth (CWM LLC) first reported a position in Vanda Pharmaceuticals in Q1 2019 and has held it in 28 quarters since.
  • 171 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.